Sfoglia per Autore
Nail changes as manifestation of systemic disease in COVID‐19 infection
2021 Ocampo‐garza, Ss; Ocampo‐candiani, J; Camela, E; Vastarella, M; Fabbrocini, G; Scalvenzi, M; Villani, A
Efficacy and Safety of Dupilumab in Clinical Practice:One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre
2021 Napolitano, M.; Ferrillo, M.; Patruno, C.; Scalvenzi, M.; D'Andrea, M.; Fabbrocini, G.
Community Knowledge About the Use, Reuse, Disinfection and Disposal of Masks and Filtering Facepiece Respirators: Results of a Study Conducted in a Dermatology Clinic at the University of Naples in Italy
2021 Scalvenzi, M.; Villani, A.; Ruggiero, A.
Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment
2021 Napolitano, M.; Caiazzo, G.; Fabbrocini, G.; Balato, A.; Di Caprio, R.; Scala, E.; Scalvenzi, M.; Patruno, C.
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview
2021 Villani, A.; Scalvenzi, M.; Peduto, T.; Cinelli, E.; Fabbrocini, G.; Di Stefani, A.
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
2020 Scalvenzi, M.; Cappello, M.; Costa, C.; Fabbrocini, G.; Luciano, M.; Villani, A.
Second primary melanoma: incidence rate and risk factors
2020 Villani, A.; Fabbrocini, G.; Costa, C.; Greco, V.; Scalvenzi, M.
Comment on: “Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring”
2020 Villani, A.; Fabbrocini, G.; Greco, V.; Costa, C.; Scalvenzi, M.
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis
2020 Ferrillo, M; Patruno, C; Villani, A; Scalvenzi, M; Fabbrocini, G; D'Andrea, M; Napolitano, M
Drug holiday regimen for vismodegib treatment in patients with multiple primary basal cell carcinomas
2020 Villani, A.; Costa, C.; Fabbrocini, G.; Scalvenzi, M.
Dermoscopic patterns of intradermal naevi
2020 Greco, Vincenzo; Cappello, Milena; Megna, Matteo; Costa, Claudia; Villani, Alessia; Fabbrocini, Gabriella; Marino, Vincenzo; Scalvenzi, Massimiliano
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic
2020 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study
2020 Scalvenzi, Massimiliano; Megna, Matteo; Costa, Claudia; Fabbrocini, Gabriella; Villani, Alessia; Greco, Vincenzo
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018
2020 Villani, A.; Costa, C.; Fabbrocini, G.; Cinelli, E.; Greco, V.; Scalvenzi, M.
Teledermatology and chronic skin diseases: real life experience in a Southern Italian Dermatologic Centre
2020 Villani, Alessia; Megna, Matteo; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Ruggiero, Angelo
Teledermatology: a useful tool to fight COVID-19
2020 Villani, A.; Scalvenzi, M.; Fabbrocini, G.
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency
2020 Ruggiero, Angelo; Megna, Matteo; Annunziata, Maria Carmela; Abategiovanni, Luisa; Scalvenzi, Massimiliano; Tajani, Andrea; Fabbrocini, Gabriella; Villani, Alessia
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
2020 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Leiomyoma of the finger in a patient affected by cutaneous Kaposi's sarcoma
2020 Scalvenzi, Massimiliano; Costa, Claudia; Villani, Alessia; Cappello, Milena; Mascolo, Massimo; Pagliuca, Francesca; Fabbrocini, Gabriella; De Fata Salvatores, Gaia
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series"
2020 Villani, Alessia; Costa, Claudia; Fabbrocini, Gabriella; Cappello, Milena; Scalvenzi, Massimiliano
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Nail changes as manifestation of systemic disease in COVID‐19 infection | 1.1 Articolo in rivista | 2021 | Ocampo‐garza, Ss; Ocampo‐candiani, J; Camela, E; Vastarella, M; Fabbrocini, G; Scalvenzi, M; Villani, A | |
Efficacy and Safety of Dupilumab in Clinical Practice:One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre | 1.1 Articolo in rivista | 2021 | Napolitano, M.; Ferrillo, M.; Patruno, C.; Scalvenzi, M.; D'Andrea, M.; Fabbrocini, G. | |
Community Knowledge About the Use, Reuse, Disinfection and Disposal of Masks and Filtering Facepiece Respirators: Results of a Study Conducted in a Dermatology Clinic at the University of Naples in Italy | 1.1 Articolo in rivista | 2021 | Scalvenzi, M.; Villani, A.; Ruggiero, A. | |
Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment | 1.1 Articolo in rivista | 2021 | Napolitano, M.; Caiazzo, G.; Fabbrocini, G.; Balato, A.; Di Caprio, R.; Scala, E.; Scalvenzi, M.; Patruno, C. | |
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview | 1.1 Articolo in rivista | 2021 | Villani, A.; Scalvenzi, M.; Peduto, T.; Cinelli, E.; Fabbrocini, G.; Di Stefani, A. | |
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity | 1.1 Articolo in rivista | 2020 | Scalvenzi, M.; Cappello, M.; Costa, C.; Fabbrocini, G.; Luciano, M.; Villani, A. | |
Second primary melanoma: incidence rate and risk factors | 1.1 Articolo in rivista | 2020 | Villani, A.; Fabbrocini, G.; Costa, C.; Greco, V.; Scalvenzi, M. | |
Comment on: “Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring” | 1.1 Articolo in rivista | 2020 | Villani, A.; Fabbrocini, G.; Greco, V.; Costa, C.; Scalvenzi, M. | |
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis | 1.1 Articolo in rivista | 2020 | Ferrillo, M; Patruno, C; Villani, A; Scalvenzi, M; Fabbrocini, G; D'Andrea, M; Napolitano, M | |
Drug holiday regimen for vismodegib treatment in patients with multiple primary basal cell carcinomas | 1.1 Articolo in rivista | 2020 | Villani, A.; Costa, C.; Fabbrocini, G.; Scalvenzi, M. | |
Dermoscopic patterns of intradermal naevi | 1.1 Articolo in rivista | 2020 | Greco, Vincenzo; Cappello, Milena; Megna, Matteo; Costa, Claudia; Villani, Alessia; Fabbrocini, Gabriella; Marino, Vincenzo; Scalvenzi, Massimiliano | |
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic | 1.1 Articolo in rivista | 2020 | Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M. | |
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study | 1.1 Articolo in rivista | 2020 | Scalvenzi, Massimiliano; Megna, Matteo; Costa, Claudia; Fabbrocini, Gabriella; Villani, Alessia; Greco, Vincenzo | |
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 | 1.1 Articolo in rivista | 2020 | Villani, A.; Costa, C.; Fabbrocini, G.; Cinelli, E.; Greco, V.; Scalvenzi, M. | |
Teledermatology and chronic skin diseases: real life experience in a Southern Italian Dermatologic Centre | 1.1 Articolo in rivista | 2020 | Villani, Alessia; Megna, Matteo; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Ruggiero, Angelo | |
Teledermatology: a useful tool to fight COVID-19 | 1.1 Articolo in rivista | 2020 | Villani, A.; Scalvenzi, M.; Fabbrocini, G. | |
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency | 1.1 Articolo in rivista | 2020 | Ruggiero, Angelo; Megna, Matteo; Annunziata, Maria Carmela; Abategiovanni, Luisa; Scalvenzi, Massimiliano; Tajani, Andrea; Fabbrocini, Gabriella; Villani, Alessia | |
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment | 1.1 Articolo in rivista | 2020 | Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M. | |
Leiomyoma of the finger in a patient affected by cutaneous Kaposi's sarcoma | 1.1 Articolo in rivista | 2020 | Scalvenzi, Massimiliano; Costa, Claudia; Villani, Alessia; Cappello, Milena; Mascolo, Massimo; Pagliuca, Francesca; Fabbrocini, Gabriella; De Fata Salvatores, Gaia | |
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" | 1.7 Commento, erratum, replica e simili | 2020 | Villani, Alessia; Costa, Claudia; Fabbrocini, Gabriella; Cappello, Milena; Scalvenzi, Massimiliano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile